Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamineAbnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetesEffect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathyHigh-throughput screening of small molecules identifies hepcidin antagonistsAnti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trialBenfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers.Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes.Glucose effects on the peritoneum: what can we learn from rodent models?Current options and perspectives in the treatment of diabetic neuropathy.Current therapeutic interventions in the glycation pathway: evidence from clinical studies.Benfotiamine prevents increased β-amyloid production in HEK cells induced by high glucose.Benfotiamine increases glucose oxidation and downregulates NADPH oxidase 4 expression in cultured human myotubes exposed to both normal and high glucose concentrations.Solubility enhancement of benfotiamine, a lipid derivative of thiamine by solid dispersion technique.Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.Liver, plasma and erythrocyte levels of thiamine and its phosphate esters in rats with acute ethanol intoxication: a comparison of thiamine and benfotiamine administration.Human pericyte–endothelial cell interactions in co-culture models mimicking the diabetic retinal microvascular environmentInhibition of macrophage oxidative stress prevents the reduction of ABCA-1 transporter induced by advanced glycated albuminCould thiamine pyrophosphate be a regulator of the nitric oxide synthesis in the endothelial cell of diabetic patients?
P921
Q28484678-AE8714D8-4EB5-4A9A-A2EB-241088BFAC93Q34299928-9214302A-9D08-4401-B2EF-29B1AC9B0A19Q34336244-DFE5E445-7405-4B2C-8D79-D76264108FF0Q34537717-55010514-9743-49AA-8B99-B9C015A21EE2Q35645348-EA6E4F1D-3C28-4E84-AE00-3AB087B9ED4CQ35898307-45DD072F-2007-489B-A19A-F11F2915F1F9Q36317895-6322DE8E-8322-48F6-93DF-D602ED3E958CQ36747422-7ED237C1-1A2A-4365-97E3-1354F6E559F0Q37991991-91AD6356-1E30-433A-987B-C968C5EB3214Q38070740-3B62D24F-E63A-40AA-8255-310B62D779ADQ38070906-7F00B8B5-71E8-44DF-B15E-CFC9E9EA2BB7Q41453395-9E31017B-9287-4D62-ACB5-00A47D0EB38CQ42116189-A0854583-6AF9-4E4B-B9E0-4C6A8AC67767Q42432174-258C5BEC-5D3C-4156-A12F-B1478DCA2C76Q42722791-40D43DA0-DB7E-4BB5-986D-272C2D365AC0Q43920698-5670CE21-A008-42B1-B56C-E3F740563A4FQ59621015-0934B93E-D7DA-402A-A881-EEF7C64F6B4EQ83311294-96A0E85F-8F8F-4F92-8BBC-FCA57EF5FBD7Q83355148-A5C6ECBC-3B3D-4E59-BEB6-5D820B255B7F
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Benfotiamiini
@fi
Benfotiamin
@de
Benfotiamin
@sh
Benfotiamin
@sr
Benfotiamine
@en
Benfotiamine
@zh-hant
Benfotiamină
@ro
Бенфотиамин
@ru
ベンフォチアミン
@ja
type
label
Benfotiamiini
@fi
Benfotiamin
@de
Benfotiamin
@sh
Benfotiamin
@sr
Benfotiamine
@en
Benfotiamine
@zh-hant
Benfotiamină
@ro
Бенфотиамин
@ru
ベンフォチアミン
@ja
altLabel
Benfotiamiini, B1-vitamiinin rasvahakuinen muoto
@fi
prefLabel
Benfotiamiini
@fi
Benfotiamin
@de
Benfotiamin
@sh
Benfotiamin
@sr
Benfotiamine
@en
Benfotiamine
@zh-hant
Benfotiamină
@ro
Бенфотиамин
@ru
ベンフォチアミン
@ja
P486
P592
P6366
P646
P661
P662
P683
P2017
CC(N(CC1=C(N)N=C(C)N=C1)C=O)=C(CCOP(O)(O)=O)SC(=O)C2=CC=CC=C2
P2067
466.107592
P231
22457-89-2
P232
P233
CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C
P234
1S/C19H23N4O6PS/c1-13(23(12-24 ...... 20,21,22)(H2,26,27,28)/b17-13-
P235
BTNNPSLJPBRMLZ-LGMDPLHJSA-N
P2566
100.040.906
P267
P274
C₁₉H₂₃N₄O₆PS